176 results about "Blood cholesterol" patented technology

The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans.

The invention relates to a thin-film material for an optical fiber biosensor probe and a preparation method thereof. The material has catalytic characteristic and photosensitivity and is made from Fe3O4/SiO2 magnetic nanocomposite particles, bioactive enzyme, fluorescent material and sol-gel. The bioactive enzyme is fixed on the Fe3O4/SiO2 magnetic nanocomposite particles and the fixed bioactive enzyme and the fluorescent material are embedded in a sol-gel grid. The preparation method comprises the following steps: a Fe3O4/SiO2 magnetic nanocomposite particle carrier is synthesized; the carrier is activated by glutaraldehyde or by glutaraldehyde, bovine serum albumin and glutaraldehyde in sequence and then has a crosslinking reaction with the bioactive enzyme to fix the enzyme; the Fe3O4/SiO2 magnetic nanocomposite particles fixed with the bioactive enzyme are dripped on the surface of a treated glass substrate after being mixed with the sol-gel liquid blended with a Ru(bpy)3Cl2 fluorescent indicator; after cleaning, drying and aging, a sol-gel optical bio-composite sensing film embedding the bioactive enzyme and the fluorescent indicator is obtained. The optical fiber biosensor probe made from the thin-film material is especially applicable to the detection of blood sugar, blood cholesterol and the like.

The invention discloses sugar-free homogenate diet which is characterized by being prepared by mixing the puffing rice meal, puffing corn meal, puffing oat meal, soy protein, controlled-release maltodextrin, dietary fiber, vegetable fat, whole-fat milk powder, egg powder, fish meat powder, carrot powder, isomalt, mineral premix and vitamin prefix. The product disclosed by the invention is rich insoluble dietary fiber as well as insoluble dietary fiber, can obviously slow the digestive absorption of glucose after eating so as to reduce glycemic index, and can obviously improve the intestines and stomach functions and reduce the blood cholesterol level; particularly, the product contains trivalent chromium which plays an important part in regulating glycometabolism and keeping normal tolerance in vivo and also acts on the transphosphorylase in glucose metabolism to prevent and cure diabetes mellitus; and moreover, the carbohydrate of the product is high-molecular carbohydrate such as controlled-release maltodextrin, oats, corn and the like, and sugar alcohol not influencing the blood sugar level is also added.

This invention provides compositions and methods related to the administration of psyllium husk, Î<2>-sitosterol, guggul tree extract, guar gum and chromium as a combination to reduce or control blood cholesterol, triglycerides, low density lipoproteins, blood sugar or increasing or controlling high density lipoproteins in a mammal, to reduce arterial plaque build-up, atherosclerosis, in a mammal which may be associated with cardiovascular, cerebrovascular, peripheral vascular, or intestinal vascular disorders.

To provide a bacterium belonging to the genus Bifidobacterium which is excellent in a survival ability in the gastrointestinal tract, has an effect of inhibiting the cholesterol absorption in the intestinal tract, and is excellent in lipid metabolism ameliorating effects including decreasing the blood cholesterol level and the like, and shows a high survival rate after storage, and a cholesterol absorption inhibitor using the same. The invention provides a cholesterol absorption inhibitor containing, as an active ingredient, at least one microorganism selected from Bifidobacterium animalis subsp. animalis YIT 10394, Bifidobacterium animalis subsp. lactis JCM 1253, Bifidobacterium animalis subsp. lactis JCM 7117, and Bifidobacterium pseudolongum subsp. globosum.

The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized swallowable tablet and a method for reducing blood cholesterol in humans.

The invention discloses functional camellia oil, which is obtained by mixing, stirring and filtering raw materials comprising the following ingredients in parts by mass: 928.8 to 989.3 parts of camellia oleifera seed oil, 10 to 70 parts of plant sterol ester, 0.1 to 0.7 part of rosemary and 0.1 to 1 part of vitamin E. The functional camellia oil has the advantages that the stability is good, the shelf life is long, the effect of obviously reducing blood cholesterol, triglyceride and low-density lipoprotein cholesterin is realized, the cardiovascular and cerebrovascular diseases can be effectively prevented, and good stability is realized during high-temperature cooking.

The invention discloses a biologic emulsifier for livestock feed. The biologic emulsifier is characterized by being prepared by two or more than two of sophorolipid, rhamnolipid and trehalose. The sophorolipid, the rhamnolipid and the trehalose and the like in the emulsifier are all secondary metabolites generated by microbial fermentation, can be naturally metabolized and degraded, do not cause residues in animal bodies, and do not influence quality of animal products. The biologic emulsifier can remarkably improve livestock fat digestion utilizing rate, improves feed reward, reduces livestock blood cholesterol and triglyceride, remarkably improves livestock production performances, improves carcass quality, improves body immune function, reduces morbidity and mortality, and remarkably improves economic returns.

A method for treating age related macular degeneration (AMD) using an insulin preparation applied topically to the conjunctival sac of the affected eye. Another aspect of this invention is using antiangiogenic adjuvant therapeutic agents such as bevacizumab, ranibizumab, pegaptanib, etanercept, instilled in to the afflicted eye conjunctival sac with insulin to prevent further formation of new blood vessels, and shrink the existing pathologically formed blood vessels and reduce the edema in wet AMD. This method incorporates putting the patients on low fat diet, aerobic exercise, ketamine-a NMDA blocker, reducing the blood cholesterol using adjuvant therapeutic agents selected from Statins, that are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A, (i.e. HMG-Co A) reductase which in turn reduce drusen formation that leads to AMD, combined with insulin ophthalmic drops.

The present invention provides the tripeptide MAP and/or the tripeptide ITP and/or salts thereof for use as a health benefit agent, especially in functional food products. The tripeptides have particular application in the areas of the prevention of obesity or body weight control and cardiovascular health maintenance, especially the inhibition of angiotensin-converting enzyme and the control of blood cholesterol levels. Functional Food products comprising these tripeptides and having health benefits in these areas, and a process for making these products, are also provided. The tripeptides can be conveniently incorporated into food products to provide the aforementioned health benefits to the consumer thereof.

Disclosed are a test strip and a method for measuring medical data. The test strip comprises an upper cover having one or more application holes; a lower support having one or more detected parts at positions corresponding to detecting units of the measuring apparatus; an erythrocyte and LDL cholesterol-filtering layer designed to filter off both of erythrocytes and LDL cholesterol from an applied blood sample by agglutinating erythrocytes and precipitating LDL cholesterol; and a reaction layer in which the blood sample free of erythrocytes and LDL cholesterol is reacted with an reagent, the filtering layer and the reaction layer being stacked between the lower support and the upper cover. Structured to filter off erythrocytes and low-density lipoprotein (LDL) cholesterol from a blood sample in a single layer, the test strip of the present invention can be made to be slim and allows a low volume of blood to be analyzed.

The present invention provides an antiobesity composition comprising extract of Melissa as an active ingredient, use of Melissa extract, and a method for suppressing obesity using the composition. Also, the present invention provides an antiobesity composition comprising extract of Melissa and extract of Mori Folium as active ingredients, use of a mixture of Melissa extract and Mori Folium extract, and a method for suppressing obesity using the composition. Further, the present invention provides an antiobesity composition comprising extract of Melissa, extract of Artemisia and extract of Mori Folium as active ingredients, use of a mixture of Melissa extract, Artemisia extract and Mori Folium extract, and a method for suppressing obesity using the composition. When the present compositions are administrated into genetically obese mice or high fat diet-induced obese mice, the present compositions reduced body weight, body fat and gonadal fat, and reduce blood cholesterol level and obesity-related blood glucose level. Also, the present compositions suppress hypertrophy of adipocytes, and inhibit the accumulation of lipid in the liver by reducing the size and number of lipid vacuoles. Furthermore, in human clinial trial the present compositions show that body weight, PIBW, body fat, especially visceral fat, apolipoprotin B concentration, ratio of total cholesterol/HDL cholesterol and ratio of LDL cholesterol/HDL cholesterol are significantly decreased, and atherogenic index is improved and muscle mass is increased. Thus, the present compositions can be usefully applied as antiobesity composition for reduction of body weight and suppression of abdominal fat, particularly, visceral fat.

The invention provides application of a cholesterol molecule imprinted membrane sensing electrode in detecting cholesterol content in blood. Specific steps in the method are as follows: (1) treating a blood sample, that is, standing the blood sample at room temperature and carrying out centrifugation to extract serum if the blood sample is obtained by drawing blood from a person who is on an empty stomach, or carrying out anticoagulation by using heparin or EDTA (ethylene diamine tetraacetic acid) if the blood sample is blood plasma; (2) dropwise adding the blood sample obtained in step (1) onto the cholesterol molecule imprinted membrane sensing electrode, inserting the cholesterol molecule imprinted membrane sensing electrode into an amperometric sensor for determination, and recording readings. When used for detecting cholesterol content in blood, the molecule imprinted membrane sensing electrode has the advantages of low cost, high sensitivity, fast analysis speed, capacity of reducing sampling amount and avoiding tedious pretreatment of blood samples, etc.

The invention relates to a health-care porridge. The porridge is made from the following components, and the weight-to-number ratio is: 30-50 parts of soybeans, 60-80 parts of sorghum, 10-30 parts of red beans, 10-30 parts of wheat kernels, And the right amount of cowpea. Through the repeated research and development of the applicant, the present invention organically combines various components according to the aforementioned ratio, and various effects complement each other, thereby effectively promoting digestion, improving sleep, and having obvious curative effects on hyperlipidemia and hypertension.

The invention discloses a fiber biscuit for promoting the digestion function. The fiber biscuit comprises, by weight, 30-50 parts of self-raising flour, 10-15 parts of low-fat milk powder, 5-8 parts of bean dreg powder, 3-5 parts of hawthorn powder, 15-20 parts of egg liquid, 10-20 parts of butter and 5-8 parts of berry sugar. The fiber biscuit is free of pollution, safe, free of toxic and side effects and free of annexing agents, and has the advantages of preventing and treating hypertension, heart diseases and arteriosclerosis, reducing the serum cholesterol concentration and promoting digestive absorption. The fiber biscuit is simple in making process, low in cost, high in production efficiency and suitable for large-scale production.

The invention provides a production process of a soy sauce flavor type soybean sauce. The soy sauce flavor type soybean sauce is prepared by using vinasse as a raw material, and aspergillus oryzae strains and bifidobacterium strains as strains. The production process is characterized in that with vinasse as the raw material, the production cost is reduced; and meanwhile, with bifidobacterium as a fermenting strain, the prepared soybean sauce contains nutritional ingredients such as lipoteichoic acid, membrane teichoic acid and peptidoglycan, so that the soybean sauce is endowed with a unique flavor, and the soybean sauce has the efficacies of enhancing the immunologic function and anti-tumour effect of the organism, relieving and removing fatigue, adjusting balance of intestinal microflora and improving the liver function, has nutritional benefits, and also has the efficacies of relieving uremia, resisting anaphylaxis, increasing the appetite, reducing blood pressure and blood cholesterol, preventing arteriosclerosis and the like, so as to promote health of a human body. The soybean sauce prepared by the production process is dark in color, and thick in juice, contains sugar but is not sweet, contains salt but is not salty, contains acid but is not sour, and has the unique thick soy sauce flavor.

The invention relates to edible oil, in particular to an edible blending oil. The invention also relates to a preparation method of the blending oil. The raw material oil of the edible blending oil comprises the following oils by weight percent: 10%-20% of tea seed soil, 20%-30% of colza oil and 50-70% of soybean oil. After the edible blending oil of the invention is prepared by blending tea seedsoil, colza oil and soybean oil, the ratio of the saturated fatty acid which has harmful effects to human cardiovascular system, to the fatty acid of the edible blending oil is reduced and the ratio of the monounsaturated fatty acid which is beneficial for human health is increased. The blending oil can fully meet the normal demand of human body for the edible oil and can not bring adverse effectsfor human body. The blending oil of the invention has active effect on inhibiting and preventing cardiovascular and cerebrovascular diseases such as hypertension, hyperlipaemia, atherosclerosis and the like, reducing blood cholesterol and triglyceride, cleaning internal lipid superoxide, moisturizing skin, etc.

The invention provides a soft capsule preparation for preventing and treating diseases of old people. The preparation comprises the following main and auxiliary raw materials in percentage by weight: 3 to 48 percent of sabal extract, 1 to 20 percent of lycoypene, 0.1 to 0.7 percent of coenzyme Q10, 0.1 to 5 percent of lecithin, 25 to 40 percent of alpha-linolenic acid, and 0.1 to 10 percent of auxiliary materials. The soft capsule preparation relates to a prescription with anti-inflammatory, anti-oxidation, blood cholesterol reduction functions, and the preparation prepared by using the prescription has the functions of inhibiting benign prostatic hyperplasia, delaying senescence, preventing cancer, preventing cardiovascular diseases, preventing senile dementia and the like.